Pharmacological inhibition of diacylglycerol acyltransferase 1 reduces body weight gain, hyperlipidemia, and hepatic steatosis in db/db mice
- 5 November 2010
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 31 (11) , 1470-1477
Abstract
Aim: Methods: Results: Conclusion:Keywords
This publication has 38 references indexed in Scilit:
- An integrative view of obesityThe American Journal of Clinical Nutrition, 2010
- Specific role for acyl CoAHepatology, 2009
- Beyond triglyceride synthesis: the dynamic functional roles of MGAT and DGAT enzymes in energy metabolismAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Acylation of Acylglycerols by Acyl Coenzyme A:Diacylglycerol Acyltransferase 1 (DGAT1)Journal of Biological Chemistry, 2008
- Oxidative Stress, Glucose Metabolism, and the Prevention of Type 2 Diabetes: Pathophysiological InsightsAntioxidants & Redox Signaling, 2007
- Dissociation of Hepatic Steatosis and Insulin Resistance in Mice Overexpressing DGAT in the LiverCell Metabolism, 2007
- Leptin Stimulates Fatty Acid Oxidation and Peroxisome Proliferator-Activated Receptor α Gene Expression in Mouse C2C12 Myoblasts by Changing the Subcellular Localization of the α2 Form of AMP-Activated Protein KinaseMolecular and Cellular Biology, 2007
- Inhibition of Triglyceride Synthesis as a Treatment Strategy for ObesityArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1Journal of Clinical Investigation, 2002
- Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinaseNature, 2002